Skip to Main

Search

Results 6,551 to 6,560 of 10,000 for ""

Fish oil supplement claims often vague, not supported by data : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/aug-fish-oil-supplement.html

Your daily dose of omega-3s may not be doing what you think it is. Most fish oil supplements on the market today have labels boasting health benefits that aren’t supported by clinical data, according to a study published in JAMA Cardiology by researchers at UT Southwestern Medical Center.

UTSW researchers identify driver of inflammatory bowel disease: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/sept-inflammatory-bowel-disease.html

Researchers at UT Southwestern Medical Center have discovered an intracellular mechanism that converts protective intestinal cells into disease-driving pathogenic cells, a finding that could lead to improved treatments for patients with inflammatory bowel disease (IBD).

Meet the Fellows: Infectious Diseases and Geographic Medicine, Internal Medicine, UT Southwestern. Dallas TX

https://www.utsouthwestern.edu/departments/internal-medicine/divisions/infectious-diseases/fellowship-programs/fellows.html

Current fellow participants and Alumni in the Infectious Diseases education programs in Internal Medicine at UT Southwestern Medical Center

Putting a protein into overdrive to heal spinal cord injuries: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/heal-spinal-cord-injuries.html

Using genetic engineering, researchers at UT Southwestern and Indiana University have reprogrammed scar-forming cells in mouse spinal cords to create new nerve cells, spurring recovery after spinal cord injury.

Inappropriate disclosure to vendor announced: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/inappropriate-disclosure-to-vendor-announced.html

UT Southwestern Medical Center has informed affected patients of an inappropriate disclosure of their names and email addresses through the use of a third-party vendor. The vendor was used to send invitations to an event for the Kidney Cancer Program.

Helping childhood-onset lupus patients stay healthy as adults: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/childhood-onset-lupus-patients.html

UT Southwestern researchers have identified factors that put patients with childhood-onset lupus at elevated risk for poor outcomes, such as end-stage renal disease or death, as they transition from pediatric to adult health care.

Racial disparities in heart failure explained: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/racial-disparities-heart-failure.html

Researchers at UT Southwestern have uncovered evidence that the higher prevalence of “malignant” enlargement of the heart among blacks contributes to the higher incidence of heart failure in this population.

Could cancer immunotherapy success depend on gut bacteria?: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/cancer-immunotherapy-gut-bacteria.html

A study by researchers revealed that gut bacteria can penetrate tumor cells and boost the effectiveness of an experimental immunotherapy that targets the CD47 protein.

UT Southwestern, Texas Health launch collaborative study to better understand COVID prevalence in DFW - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/dfw-covid-prevalence-study.html

Despite the high number of confirmed cases, the true prevalence of COVID-19 infections is believed to be underestimated due to insufficient testing capacity and a high percentage of asymptomatic people.

Researchers uncover two-drug combo that halts the growth of cancer cells : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/two-drug-combo-cancer.html

A once-daily combination treatment for those with uncontrolled Type 2 diabetes amplifies the treatment’s effects – lowering both weight and the number of hypoglycemic events, and improving quality of life and glucose control ¬– and makes participants more likely to adhere to their medications.